Hello and Welcome to Patientsville.com, Your Source for all ENABLEX information. We are dedicated to provide You with ENABLEX safety information. Learn about ENABLEX serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ENABLEX Safety Reports
Total ENABLEX reports: 779.ENABLEX FDA safety alerts: No.
Reported hospitalizations: 20.
Take ENABLEX Side Effects Survey or Share Your ENABLEX Story. Read More Here.
Showing 1-75 of 779 Next >
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Aug 02, 2000. Female patient, 72 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: gastrooesophageal reflux disease. ENABLEX dosage: 7.5 MG, QD. Patient recovered.ENABLEX problem was reported by a Health Professional from UNITED STATES on Aug 07, 2006. Male patient was diagnosed with urinary incontinence and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. ENABLEX dosage: 15 MG,QD; 7.5 MG. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Aug 09, 2006. Female patient, 87 years of age, was diagnosed with urinary incontinence and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. ENABLEX dosage: unknown. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 19, 2006. Female patient, 44 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dry mouth, eye irritation, vision blurred. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Oct 18, 2006. Female patient, 69 years of age, was diagnosed with urinary incontinence and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: rash. ENABLEX dosage: 15 MG, QD. During the same period patient was treated with NEXIUM, SYNTHROID, LIPITOR, AVALIDE, EVISTA. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 20, 2006. Female patient, 83 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dry mouth. ENABLEX dosage: 15 MG, QD, ORAL. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Oct 13, 2006. Male patient, 79 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dizziness. ENABLEX dosage: 7.5 MG, QD, ORAL. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 16, 2006. Female patient, 82 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: somnolence. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Oct 16, 2006. Female patient was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dizziness. ENABLEX dosage: 7.5 MG, QD, ORAL. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 16, 2006. Male patient, 75 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dry mouth, epistaxis. ENABLEX dosage: 15 MG, QD. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Oct 17, 2006. Female patient, 83 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: pollakiuria. ENABLEX dosage: unknown. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 17, 2006. Female patient, 77 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Oct 17, 2006. Female patient, 80 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: abdominal distension, constipation, dry mouth. ENABLEX dosage: 7.5 MG, QD, ORAL. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 06, 2006. Female patient, 70 years of age, was diagnosed with pollakiuria and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dizziness, dry eye, dry mouth, nausea. ENABLEX dosage: 15 MG, QD. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Oct 09, 2006. Female patient, 53 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: hot flush, pruritus. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 09, 2006. Female patient, 58 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: hot flush, stomach discomfort. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Oct 10, 2006. Female patient was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: constipation, dry mouth. ENABLEX dosage: 15 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2006. Female patient, 86 years of age, was diagnosed with urinary incontinence and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dry mouth, pharyngolaryngeal pain. ENABLEX dosage: 15 MG, QD. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Oct 12, 2006. Female patient, 82 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, constipation. ENABLEX dosage: 15 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2006. Female patient, 57 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: constipation. ENABLEX dosage: 15 MG, QD, ORAL. During the same period patient was treated with ZESTRIL, FOSAMAX. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Oct 16, 2006. Male patient, 83 years of age, was diagnosed with urinary incontinence and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: pollakiuria. ENABLEX dosage: 15 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 13, 2006. Female patient, 78 years of age, was diagnosed with urinary incontinence and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: constipation. ENABLEX dosage: 7.5 MG, QD, ORAL. During the same period patient was treated with DIOVAN HCT, TOPROL, NIASPAN, DDAVP, VITAMINS. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Oct 02, 2006. Male patient, 78 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: pollakiuria. ENABLEX dosage: 75. MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 02, 2006. Male patient, 49 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: cough. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Oct 02, 2006. Female patient, 76 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: pain in extremity. ENABLEX dosage: unknown. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 04, 2006. Male patient, 82 years of age, was diagnosed with pollakiuria and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: abdominal distension, constipation, dry mouth. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Oct 04, 2006. Female patient, 86 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: constipation. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 26, 2006. Male patient, 77 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: constipation, dry mouth. ENABLEX dosage: 15 MG, QD. Patient recovered.
Physician from UNITED STATES reported ENABLEX problem on Aug 07, 2006. Female patient, 72 years of age, was diagnosed with urinary incontinence and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: constipation, oedema peripheral, pollakiuria, pruritus. ENABLEX dosage: 7.5 MG, QD. During the same period patient was treated with DIOVAN, LIPIOTOR, PLAVIX, DITROPAN. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2006. Female patient, 82 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dental caries, dry mouth, pruritus, urinary incontinence. ENABLEX dosage: 15 MG, QD. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Sept 25, 2006. Male patient, 86 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: constipation, dry mouth, somnolence. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 11, 2006. Female patient, 87 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: cystitis, dry mouth, dysuria, pruritus. ENABLEX dosage: 7.5 MG, QD, ORAL 15 MG, QD, ORAL. During the same period patient was treated with PREVACID. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Aug 30, 2006. Male patient, 76 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dry mouth. ENABLEX dosage: 15 MG, QD, ORAL. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2006. Female patient, 71 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dry mouth. ENABLEX dosage: 15 MG, QD, ORAL. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Aug 06, 2006. Female patient was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dry mouth. ENABLEX dosage: 15 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 07, 2006. Female patient, 54 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dizziness, dry mouth. ENABLEX dosage: 15 MG, QD. During the same period patient was treated with PERCOCET, AMOXICILLIN. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Aug 08, 2006. Female patient, 40 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: somnolence. ENABLEX dosage: 7.5 MG, QD. During the same period patient was treated with BENADRYL. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2006. Male patient, 83 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: pollakiuria. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Aug 10, 2006. Female patient was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: somnolence. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2006. Female patient, 66 years of age, was diagnosed with hypertonic bladder, cystitis and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: urticaria. ENABLEX dosage: 15 MG, QD. During the same period patient was treated with OMNICEF, GLUCOPHAGE, ACTOS, LOTENSIN, LIPITOR, EFFEXOR. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Aug 03, 2006. Female patient, 78 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: vaginal burning sensation. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 03, 2006. Male patient was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dry mouth. ENABLEX dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Aug 03, 2006. Female patient was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: constipation. ENABLEX dosage: 15 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 04, 2006. Female patient, 55 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: constipation, dry mouth, headache, pharyngolaryngeal pain. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Aug 15, 2006. Female patient, 79 years of age, was diagnosed with cystitis and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: fungal infection, pollakiuria. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2006. Male patient, 62 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, dry mouth, dyspepsia, pollakiuria, vomiting. ENABLEX dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Oct 10, 2006. Female patient, 93 years of age, was diagnosed with urinary incontinence and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: pruritus, rash, swelling face. ENABLEX dosage: 15 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2006. Female patient, 63 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: nasal congestion. ENABLEX dosage: 15 MG, QD. Patient recovered.
Health Professional from UNITED STATES reported ENABLEX problem on Nov 06, 2006. Female patient, 67 years of age, weighting 194.0 lb, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dyspnoea. ENABLEX dosage: 7.5 MG, QD, ORAL. During the same period patient was treated with ESTRADIOL. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2006. Female patient, 83 years of age, was diagnosed with pollakiuria and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dry mouth, pollakiuria, somnolence. ENABLEX dosage: 7.5 MG, QD, ORAL. Patient recovered.
Physician from UNITED STATES reported ENABLEX problem on Oct 19, 2006. Female patient, child 10 years of age, was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: salivary hypersecretion. ENABLEX dosage: unknown. During the same period patient was treated with DEPAKOTE, LAMICTAL, MACRODANTIN, MIRALAX. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2006. Female patient, 82 years of age, was diagnosed with urinary incontinence and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: myalgia. ENABLEX dosage: 7.5 MG, QD, ORAL. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Oct 31, 2006. Female patient was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: erythema, hypertonic bladder, pruritus. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2006. Female patient, 78 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dry mouth, nocturia. ENABLEX dosage: 7.5 MG, QD. During the same period patient was treated with LIPITOR, ZYRTEC. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Sept 19, 2006. Female patient, 91 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: bladder spasm. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 05, 2006. Male patient, 85 years of age, was diagnosed with urinary incontinence and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: blood urine present, cystoscopy, urinary tract infection. ENABLEX dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Sept 07, 2006. Female patient, 59 years of age, was diagnosed with hypertonic bladder, impaired gastric emptying and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: feeling jittery, nervousness. ENABLEX dosage: unknown. During the same period patient was treated with ZELNORM. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 07, 2006. Female patient, 64 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: abdominal pain, urinary tract infection. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Mar 11, 2006. Female patient, 74 years of age, was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: blood urine present. ENABLEX dosage: unknown. Patient recovered.
ENABLEX problem was reported by a Pharmacist from UNITED STATES on Sept 11, 2006. Male patient, 64 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: muscle spasms. ENABLEX dosage: 7.5 MG, QD. During the same period patient was treated with UROXATRAL. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Sept 11, 2006. Male patient, 88 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: fatigue, somnolence. ENABLEX dosage: unknown. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 11, 2006. Female patient was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. ENABLEX dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Sept 12, 2006. Male patient was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: initial insomnia, pollakiuria. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2006. Female patient was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: headache. ENABLEX dosage: 15 MG, QD. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Aug 14, 2006. Female patient, 37 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dyspepsia. ENABLEX dosage: unknown. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2006. Female patient, 82 years of age, was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: lacrimation increased, pollakiuria, rhinorrhoea. ENABLEX dosage: unknown. During the same period patient was treated with GLIPIZIDE, SYNTHROID, VITAMINS. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Aug 15, 2006. Female patient, 72 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: pollakiuria. ENABLEX dosage: 15 MG, QD. Patient recovered.
ENABLEX problem was reported by a Health Professional from UNITED STATES on Aug 16, 2006. Female patient, 92 years of age, was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: constipation, sneezing. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Aug 22, 2006. Female patient, 72 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dry mouth. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 23, 2006. Female patient, 71 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: nausea. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
Physician from UNITED STATES reported ENABLEX problem on Aug 23, 2006. Male patient, 78 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dizziness, somnolence. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 23, 2006. Male patient, 75 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: breast tenderness. ENABLEX dosage: 7.5 MG, QD. During the same period patient was treated with LEVOTHYROXINE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Aug 23, 2006. Male patient was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dry mouth. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 23, 2006. Female patient, 61 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: vision blurred. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ENABLEX problem on Aug 24, 2006. Female patient, 71 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: dizziness, dry mouth. ENABLEX dosage: 7.5 MG, QD. Patient recovered.
Showing 1-75 of 779 Next >